Product Information

RIVASTIGMINE 1.5 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.1685 per EA under NDC 60687077701. Its NADAC has been published 143 times since Feb 28, 2024.

FDA first approved this application on Oct 31, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Rivastigmine Tartrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RIVASTIGMINE 1.5 MG CAPSULE

Rivastigmine Tartrate
$0.1685per EA
Low Outlier

Strength

1.5 mg/1

NDC

60687077701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077130

FDA Approved

10/31/2007

TE Code

AB

On Market Since

1/1/2024

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for RIVASTIGMINE 1.5 MG CAPSULE has been published 143 times since Feb 28, 2024, and over the history we have for it it has declined 20.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1685 per EA
All-time high$0.2112 (Mar 13, 2024)
All-time low$0.1458 (Jan 21, 2026)
52-week high$0.1693
52-week low$0.1458
Median price$0.1681
Average price$0.1705
Largest weekly change+29.7% (Aug 21, 2024)
Weeks tracked143
Tracking sinceFeb 28, 2024

Price History

1W

+0.2%

1M

+2.6%

3M

+5.9%

6M

+3.8%

1Y

-9.6%

3Y

N/A

5Y

N/A

All

-20.2%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIVASTIGMINE 1.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 1.5 MG CAPSULE, manufactured by American Health Packaging, is $0.1685 per EA (NDC 60687077701), effective Nov 18, 2026.

How has the price of RIVASTIGMINE 1.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has declined 20.2%. It has been tracked across 143 weekly CMS publications since Feb 28, 2024.

What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 1.5 MG CAPSULE?

Since Feb 28, 2024, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has ranged from a low of $0.1458 (Jan 21, 2026) to a high of $0.2112 (Mar 13, 2024), with a median of $0.1681 per EA.

Are there cheaper alternatives to RIVASTIGMINE 1.5 MG CAPSULE?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIVASTIGMINE 1.5 MG CAPSULE, is $0.1508 per EA — about 11% below RIVASTIGMINE 1.5 MG CAPSULE.

Who manufactures RIVASTIGMINE 1.5 MG CAPSULE?

RIVASTIGMINE 1.5 MG CAPSULE (NDC 60687077701) is labeled by American Health Packaging, and CMS classifies it as a generic product.